Axsome Therapeutics (NASDAQ:AXSM) Raised to Strong-Buy at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports. A number of other equities research analysts have also recently issued reports on the stock. Bank of America boosted their target price on shares of Axsome Therapeutics from $143.00 to $167.00 and […]
Cantor Fitzgerald upgraded shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports. A number of other equities research analysts have also recently issued reports on the stock. Bank of America boosted their target price on shares of Axsome Therapeutics from $143.00 to $167.00 and […]
